← All Ascentage Pharma Group International filings

Ascentage Pharma Group International F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
AAPG
Ascentage Pharma Group International
F-1/A: Ascentage Pharma Eyes Nasdaq Listing with 7.325 Million ADS Offering
Ascentage Pharma is set to launch its initial public offering in the U.S., offering 7,325,000 American Depositary Shares (ADS) while already listed on the Hong Kong Stock Exchange.
NASDAQ
AAPG
Ascentage Pharma Group International
F-1: Ascentage Pharma Eyes Nasdaq Listing with Proposed IPO
Ascentage Pharma, a global biopharmaceutical company, has filed for an initial public offering (IPO) in the United States to list its American depositary shares (ADSs) on the Nasdaq Global Market.